Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DMAC

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DMAC
DateTimeSourceHeadlineSymbolCompany
05/06/20198:54AMGlobeNewswire Inc.DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019NASDAQ:DMACDiaMedica Therapeutics Inc
04/30/20194:58PMGlobeNewswire Inc.DiaMedica Therapeutics to Present at CKD3 Kidney Summit MeetingNASDAQ:DMACDiaMedica Therapeutics Inc
04/29/20194:34PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
04/08/20196:09AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMACDiaMedica Therapeutics Inc
04/08/20196:06AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DMACDiaMedica Therapeutics Inc
03/29/20194:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
03/20/20194:33PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DMACDiaMedica Therapeutics Inc
03/19/20195:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
03/19/20195:00PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:DMACDiaMedica Therapeutics Inc
03/19/20194:30PMGlobeNewswire Inc.DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate UpdateNASDAQ:DMACDiaMedica Therapeutics Inc
03/18/20191:56PMGlobeNewswire Inc.DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference CallNASDAQ:DMACDiaMedica Therapeutics Inc
03/12/20191:00PMGlobeNewswire Inc.DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019NASDAQ:DMACDiaMedica Therapeutics Inc
02/26/20198:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
02/14/20198:00AMGlobeNewswire Inc.DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney DiseaseNASDAQ:DMACDiaMedica Therapeutics Inc
02/01/20194:33PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
01/29/20194:33PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
01/24/20194:56PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
01/22/20197:45AMGlobeNewswire Inc.DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke...NASDAQ:DMACDiaMedica Therapeutics Inc
01/16/20194:00PMPR Newswire (US)OTC Markets Group Announces Quarterly Index Performance and RebalancingNASDAQ:DMACDiaMedica Therapeutics Inc
01/09/20195:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
01/09/20195:00PMGlobeNewswire Inc.DiaMedica Therapeutics Announces Voluntary Delisting from TSX Venture ExchangeNASDAQ:DMACDiaMedica Therapeutics Inc
01/03/201910:41AMGlobeNewswire Inc.UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney DiseaseNASDAQ:DMACDiaMedica Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DMAC